We used three AGO2 specific shRNAs to knock down AGO2 in a human nasopharyngeal carcinoma cell line CNE2Z, and western blots assay confirmed that the protein expression level of AGO2 was remarkably decreased in CNE2Z cells after AGO2 knockdown (Fig. 2a). The gene discussed is AGO2; the disease is nasopharyngeal carcinoma.